Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Sanchi Pharmaceutical is a specialized pharmaceutical company based in Wenshan, Yunnan, the primary production region for Panax notoginseng (Sanchi). The company focuses on the research, development, and large-scale production of traditional Chinese medicine (TCM) products derived from Sanchi, which is renowned for its blood-circulating and anti-inflammatory properties. Its product portfolio includes various formulations such as capsules, tablets, and powders used primarily for treating cardiovascular and cerebrovascular conditions. As a key player in the Sanchi industry, the company integrates cultivation, processing, and pharmaceutical manufacturing to ensure high-quality botanical extracts for the domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Sanchi Pharmaceutical.